Cell therapy manufacturing is uniquely vulnerable to contamination, variability, and operational burden because the product - ...

Upperton has submitted an application to the UK’s Medicines and Healthcare Products Regulatory Agency for approval of its new sterile manufacturing facility.

Upperton Pharma Solutions submits MHRA application for a new Annex 1–compliant sterile manufacturing facility, expanding clinical-scale CDMO capacity for biotech and pharma companies.

Aseptic processing improvements aim to reduce contamination from operators, yet interventions remain necessary, increasing contamination risk. 'Inherent' and 'corrective' interventions are ...

Please define the meaning of “risk” from the perspective of environmental monitoring. Risk assessment consists of the identification of hazards and the analysis and evaluation of risks associated with ...

Dublin, July 28, 2025 (GLOBE NEWSWIRE) -- The "New EU (European Union) GMP (Good Manufacturing Practice) Annex 1: Compliant Aseptic Operations Training Course" has been added to ResearchAndMarkets.com ...

Traditionally, vaccine manufacture has accounted for a huge amount of aseptic production. In recent years, there has been a larger focus on novel biologic therapies, of which the majority are ...

Aseptic blow-fill-seal (B/F/S) systems for the processing of pharmaceutical liquids have experienced rapid and growing acceptance by the pharmaceutical industry over the past 20 years. This has been ...

Modern grocery store shelves are filled with shelf-stable packaged foods. Everything from vegetables to dairy and meat products can be prepackaged and stored without the need for refrigeration, making ...

Limited remote, continuous measurement and poor instrument/software interconnectivity impede manufacturing management (enterprise) system deployment and restrict the use of analytical results for real ...

Dublin, Aug. 07, 2024 (GLOBE NEWSWIRE) -- The "New EU (European Union) GMP (Good Manufacturing Practice) Annex 1: Compliant Aseptic Operations Training Course" conference has been added to ...

According to the National Cancer Institute, immunotherapies that enlist and strengthen the power of a patient’s immune system are the “fifth pillar” of cancer treatment adding to surgery, chemotherapy ...